New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

Stakeholders at the Transportation Research Board annual meeting gathered to evaluate port performance, a complicated ...

The "Magnificent Seven" is a group of seven tech-orientated companies -- Microsoft (NASDAQ: MSFT), Apple, Nvidia, Alphabet, ...

A prototype AI chatbot tool has been developed to help pull together vital human, animal and environmental health information to support the global response to antimicrobial resistance (AMR).

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.

Discover how NotebookLM and Perplexity streamline AI research, saving you time while delivering actionable insights for any ...

Researchers at the University of Calgary developed a new vaccine to fight against the deadly livestock disease, hemorrhagic ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

A single third-trimester iron infusion significantly reduces anemia in pregnant women, outperforming oral iron tablets and ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

TD Cowen analyst Jack Ayers maintained a Buy rating on Embraer SA (ERJ – Research Report) yesterday and set a price target of $50.00. The ...

University of Bergen researcher Markus Miettinen is among the first scientists to provide a detailed description of protein ...